ARG21952

Mouse anti-Human IgG2 (Fc) antibody [31-7-4] (HRP)

Mouse anti-Human IgG2 (Fc) antibody [31-7-4] (HRP) for ELISA,ELISPOT,Flow cytometry,FLISA,ICC/IF,Western blot and Human

publication_link Publication2

Overview

Product Description HRP-conjugated Mouse Monoclonal antibody [31-7-4] recognizes Human IgG2 (Fc)
Tested Reactivity Hu
Tested Application ELISA, ELISPOT, FACS, FLISA, ICC/IF, WB
Host Mouse
Clonality Monoclonal
Clone 31-7-4
Isotype IgG1, kappa
Target Name IgG2 (Fc)
Immunogen Human IgG2 myeloma protein
Conjugation HRP

Application Instructions

Application Suggestion
Tested Application Dilution
ELISA1:2000 - 1:8000
ELISPOTAssay-dependent
FACSAssay-dependent
FLISAAssay-dependent
ICC/IFAssay-dependent
WBAssay-dependent
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Buffer 50% PBS (pH 7.4) and 50% Glycerol
Stabilizer 50% Glycerol
Storage Instruction Aliquot and store in the dark at 2-8°C. Keep protected from prolonged exposure to light. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Images (1) Click the Picture to Zoom In

  • ARG21952 Mouse anti-Human IgG2 (Fc) antibody [31-7-4] (HRP) ELISA image

    ELISA: The plate was coated with purified Human IgG1, IgG2, IgG3, and IgG4. Immunoglobulins were detected with serially diluted ARG21952 Mouse anti-Human IgG2 (Fc) antibody [31-7-4] (HRP).

Specific References

Pathogenetic associations of anti-ribosomal P protein antibody titres and its subclasses in patients with systemic lupus erythematosus

ELISA / 

Yoshikatsu Kaneko et al.
Rheumatology (Oxford).,  (2023)

publication_link

 

hr_line

Comparative analysis of IgG and IgG subclasses against Plasmodium falciparum MSP-119 in children from five contrasting bioecological zones of Cameroon.

ELISA / Human

Kwenti TE et al.
Malar J.,  (2019)

publication_link

 

hr_line